Comparison of clinical features by primary site in patients with biliary tract cancer who received gemcitabine-based chemotherapy: an exploratory analysis of JCOG1113

Yuko Suzuki, Masafumi Ikeda, Junki Mizusawa, Yusuke Sano, Chigusa Morizane, Takuji Okusaka, Satoshi Kobayashi, Hiroshi Imaoka, Takeshi Terashima, Naohiro Okano, Haruo Miwa, Akiko Todaka, Satoshi Shimizu, Nobumasa Mizuno, Sohei Satoi, Keiji Sano, Kazutoshi Tobimatsu, Akio Katanuma, Masato Ozaka, Makoto Ueno

Open source

DOI
10.1007/s10147-025-02834-x
Published
2025-07-24
Container
International Journal of Clinical Oncology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s10147-025-02834-x,
  title = {Comparison of clinical features by primary site in patients with biliary tract cancer who received gemcitabine-based chemotherapy: an exploratory analysis of JCOG1113},
  author = {Yuko Suzuki and Masafumi Ikeda and Junki Mizusawa and Yusuke Sano and Chigusa Morizane and Takuji Okusaka and Satoshi Kobayashi and Hiroshi Imaoka and Takeshi Terashima and Naohiro Okano and Haruo Miwa and Akiko Todaka and Satoshi Shimizu and Nobumasa Mizuno and Sohei Satoi and Keiji Sano and Kazutoshi Tobimatsu and Akio Katanuma and Masato Ozaka and Makoto Ueno},
  year = {2025},
  journal = {International Journal of Clinical Oncology},
  doi = {10.1007/s10147-025-02834-x},
  url = {https://doi.org/10.1007/s10147-025-02834-x}
}

RIS

TY  - JOUR
TI  - Comparison of clinical features by primary site in patients with biliary tract cancer who received gemcitabine-based chemotherapy: an exploratory analysis of JCOG1113
AU  - Yuko Suzuki
AU  - Masafumi Ikeda
AU  - Junki Mizusawa
AU  - Yusuke Sano
AU  - Chigusa Morizane
AU  - Takuji Okusaka
AU  - Satoshi Kobayashi
AU  - Hiroshi Imaoka
AU  - Takeshi Terashima
AU  - Naohiro Okano
AU  - Haruo Miwa
AU  - Akiko Todaka
AU  - Satoshi Shimizu
AU  - Nobumasa Mizuno
AU  - Sohei Satoi
AU  - Keiji Sano
AU  - Kazutoshi Tobimatsu
AU  - Akio Katanuma
AU  - Masato Ozaka
AU  - Makoto Ueno
PY  - 2025
JO  - International Journal of Clinical Oncology
DO  - 10.1007/s10147-025-02834-x
UR  - https://doi.org/10.1007/s10147-025-02834-x
ER  - 

APA

Suzuki, Y., Ikeda, M., Mizusawa, J., Sano, Y., Morizane, C., Okusaka, T., Kobayashi, S., Imaoka, H., Terashima, T., Okano, N., Miwa, H., Todaka, A., Shimizu, S., Mizuno, N., Satoi, S., Sano, K., Tobimatsu, K., Katanuma, A., Ozaka, M., & Ueno, M. (2025). Comparison of clinical features by primary site in patients with biliary tract cancer who received gemcitabine-based chemotherapy: an exploratory analysis of JCOG1113. International Journal of Clinical Oncology. https://doi.org/10.1007/s10147-025-02834-x

Source records